Assembly Biosciences, Inc.
ASMB
$10.70
$0.171.61%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 5.72% | 33.34% | 34.00% | 52.10% | 51.05% |
| Total Depreciation and Amortization | -61.90% | -71.55% | -74.60% | -74.19% | -32.26% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -50.34% | -81.26% | -87.89% | -106.29% | -63.18% |
| Change in Net Operating Assets | -88.76% | -405.16% | -590.06% | -26.42% | 37,510.81% |
| Cash from Operations | -100.55% | -10.08% | -25.49% | 21.62% | 482.50% |
| Capital Expenditure | 100.00% | 100.00% | 70.83% | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -98.40% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 92.53% | 28.77% | 161.57% | 72.86% | -694.92% |
| Cash from Investing | 92.53% | 29.70% | 161.05% | 72.72% | -641.32% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 84.89% | -- | 9,194.03% | -- | 2,003.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 84.89% | -- | 9,194.03% | -- | 2,003.43% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 245.15% | 83.67% | 102.10% | 87.78% | -202.22% |